Morning Overview on MSN
The FDA cleared its first blood test to flag prostate cancer in men with high PSA
An elevated PSA reading has long put men in an uncomfortable position: it signals possible prostate cancer, but it is ...
Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who ...
Prostate Cancer UK have paid tribute to broadcaster Dermot Murnaghan, describing him as a "passionate and dedicated supporter" of the charity. The charity said his decision to share his diagnosis ...
Morning Overview on MSN
A prostate cancer drug halved the odds of the disease spreading
Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...
Houston biopharma company CoRegen said it has received US Food and Drug Administration clearance to begin a Phase I/II trial of CRG-150, an adoptive cell therapy targeting steroid receptor coactivator ...
Scientists are asking an unusual question: what if one type of prostate cancer should no longer be called cancer? A new ...
These DeKalb doctors aren’t waiting for people to get sick. They’re bringing lifesaving screenings to the community.
Men often learn to live with discomfort. A little back pain, getting up twice at night to use the washroom, or a weak urine ...
How alcohol remains ubiquitous and socially acceptable despite its association with cancer, liver disease, and multiple other health maladies. (The Conversation) Postmenopausal women with noninvasive ...
A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could ...
The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results